Kymera Therapeutics, Inc. (KYMR)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 2.35B |
| Enterprise Value | 1.92B |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 29.67 |
| Price/Book (mrq) | 3.31 |
| Enterprise Value/Revenue | 24.14 |
| Enterprise Value/EBITDA | -12.76 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 2.27 |
| 52-Week Change 3 | 38.12% |
| S&P500 52-Week Change 3 | 25.77% |
| 52 Week High 3 | 45.31 |
| 52 Week Low 3 | 9.60 |
| 50-Day Moving Average 3 | 38.49 |
| 200-Day Moving Average 3 | 26.06 |
Share Statistics
| Avg Vol (3 month) 3 | 621.96k |
| Avg Vol (10 day) 3 | 506.2k |
| Shares Outstanding 5 | 61.36M |
| Implied Shares Outstanding 6 | 61.36M |
| Float 8 | 40.38M |
| % Held by Insiders 1 | 1.25% |
| % Held by Institutions 1 | 102.52% |
| Shares Short (Apr 15, 2024) 4 | 9.7M |
| Short Ratio (Apr 15, 2024) 4 | 14.55 |
| Short % of Float (Apr 15, 2024) 4 | 17.77% |
| Short % of Shares Outstanding (Apr 15, 2024) 4 | 15.81% |
| Shares Short (prior month Mar 15, 2024) 4 | 8.33M |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | N/A |
| Last Split Date 3 | N/A |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Mar 31, 2024 |
Profitability
| Profit Margin | -194.67% |
| Operating Margin (ttm) | -514.30% |
Management Effectiveness
| Return on Assets (ttm) | -14.60% |
| Return on Equity (ttm) | -26.35% |
Income Statement
| Revenue (ttm) | 79.41M |
| Revenue Per Share (ttm) | 1.29 |
| Quarterly Revenue Growth (yoy) | 8.70% |
| Gross Profit (ttm) | N/A |
| EBITDA | -170.46M |
| Net Income Avi to Common (ttm) | -154.59M |
| Diluted EPS (ttm) | -2.51 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 520.54M |
| Total Cash Per Share (mrq) | 8.48 |
| Total Debt (mrq) | 87.02M |
| Total Debt/Equity (mrq) | 12.24% |
| Current Ratio (mrq) | 9.57 |
| Book Value Per Share (mrq) | 11.59 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -98.45M |
| Levered Free Cash Flow (ttm) | -110.17M |
© 2024 Yahoo. All rights reserved.